Correlation of Serum Magnesium with Dyslipidemia in Maintenance Hemodialysis Patients
Acta Medica (Hradec Kralove, Czech Republic) · 2004 · 47 (4) · 263-265
DOI: 10.14712/18059694.2018.102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Medica (Hradec Kralove, Czech Republic), online erschienen am 08.11.2018. Verfasst von Hamid Nasri und 1 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
One of the factors involved in accelerated atherosclerosis in hemodialysis patients is dyslipidemia. In this study we considered factors involved in intensification of dyslipidemia in hemodialysis patients.This study was done on 36 maintenance hemodialysis patients. Serum lipoprotein (a), Triglyceride, Cholesterol, HDL-C,LDL-C and also serum Intact parathormone( iPTH), Calcium, Phosphorus, Magnesium were measured. In statistical analysis there was not any correlation between serum lipids and iPTH. There was not correlation between serum calcium with serum lipids (p>0.05). There was not correlation between CaxP product with serum lipids (p>0.05). There was a positive correlation between serum Magnesium and Lipoprotein(a) (P
Zitieren
APA
Nasri, H., & Baradaran, A. (2004). Correlation of Serum Magnesium with Dyslipidemia in Maintenance Hemodialysis Patients. Acta Medica (Hradec Kralove, Czech Republic), 47(4), 263-265. https://doi.org/10.14712/18059694.2018.102
Vancouver
Nasri H, Baradaran A. Correlation of Serum Magnesium with Dyslipidemia in Maintenance Hemodialysis Patients. Acta Medica (Hradec Kralove, Czech Republic). 2004;47(4):263-265. doi:10.14712/18059694.2018.102
BibTeX
@article{Nasri2004,
author = {Nasri, Hamid and Baradaran, Azar},
title = {Correlation of Serum Magnesium with Dyslipidemia in Maintenance Hemodialysis Patients},
journal = {Acta Medica (Hradec Kralove, Czech Republic)},
year = {2004},
volume = {47},
number = {4},
pages = {263--265},
doi = {10.14712/18059694.2018.102}
}
EUVIMED